BNTC
Benitec Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.36
+3.08%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.27
- Revenue estimate
- —
Latest reported
- Last report date
- Sep 14, 2026
- EPS actual
- -$0.26
- EPS estimate
- -$0.26
- Revenue actual
- —
- Revenue estimate
- $13.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +9.2%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 14, 2026 | -$0.26 | -$0.26 | Beat 1.62% | — |
| May 14, 2026 | -$0.27 | -$0.24 | Beat 11.11% | — |
| Feb 12, 2026 | -$0.23 | -$0.26 | Miss -13.04% | — |
| Nov 14, 2025 | -$0.35 | -$0.22 | Beat 37.14% | — |
| Sep 22, 2025 | -$0.28 | -$0.42 | Miss -50.00% | $556.0K |
| May 14, 2025 | -$0.36 | -$0.24 | Beat 33.33% | — |
| Feb 14, 2025 | -$1.00 | -$0.36 | Beat 64.00% | — |
| Nov 14, 2024 | -$0.61 | -$0.48 | Beat 21.31% | — |
| Sep 26, 2024 | -$0.49 | -$1.32 | Miss -169.39% | — |
| Feb 13, 2024 | -$0.39 | -$2.64 | Miss -576.92% | — |
| Nov 13, 2023 | -$0.51 | -$2.76 | Miss -441.18% | — |
| Sep 21, 2023 | -$3.23 | -$2.83 | Beat 12.38% | $4.6K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026